<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34129687</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4159</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>ALS-linked mutations impair UBQLN2 stress-induced biomolecular condensate assembly in cells.</ArticleTitle><Pagination><StartPage>145</StartPage><EndPage>155</EndPage><MedlinePgn>145-155</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.15453</ELocationID><Abstract><AbstractText>Mutations in ubiquilin-2 (UBQLN2), a ubiquitin-binding shuttle protein involved in several protein quality control processes, can lead to amyotrophic lateral sclerosis (ALS). We previously found that wild-type UBQLN2 forms dynamic, membraneless biomolecular condensates upon cellular stress, and undergoes liquid-liquid phase separation in vitro. However, the impact of ALS-linked mutations on UBQLN2 condensate formation in cells remains unknown. Here, we overexpress mCherry-fused UBQLN2 with five patient-derived ALS-linked mutations and employ live-cell imaging and photokinetic analysis to investigate how each of these mutations impact stress-induced UBQLN2 condensate assembly and condensate material properties. Unlike endogenous UBQLN2, exogenously introduced UBQLN2 forms condensates distinct from stress granules. Both wild-type and mutant UBQLN2 condensates are generally cytoplasmic and liquid-like. However, mutant UBQLN2 forms fewer stress-induced UBQLN2 condensates than wild-type UBQLN2. Exogenously expressed P506T UBQLN2 forms the lowest number of stress-induced condensates of all UBQLN2 mutants, and these condensates are significantly smaller than those of wild-type UBQLN2. Fluorescence recovery after photobleaching (FRAP) analysis of UBQLN2 condensates revealed higher immobile fractions for UBQLN2 mutants, especially P506T. P497S and P497H mutations differentially impact condensate properties, demonstrating that the effects of ALS-linked mutations are both position- and amino acid-dependent. Collectively, our data show that disease mutations hinder assembly and alter viscoelastic properties of stress-induced UBQLN2 condensates, potentially leading to aggregates commonly observed in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 International Society for Neurochemistry.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Julia F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-8518-9786</Identifier><AffiliationInfo><Affiliation>Department of Biology, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Neuroscience Program, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Currently at the University of Pennsylvania, Neuroscience Graduate Group, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fioramonti</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Biology, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusnock</LastName><ForeName>Amber K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Biology, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hehnly</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biology, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casta&#xf1;eda</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-9634-0867</Identifier><AffiliationInfo><Affiliation>Department of Biology, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Neuroscience Program, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinspired Institute, Syracuse University, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM127621</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM130874</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM136946</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD026946</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061848" MajorTopicYN="N">Optical Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">arsenite stress</Keyword><Keyword MajorTopicYN="N">biomolecular condensates</Keyword><Keyword MajorTopicYN="N">neurodegenerative disorders</Keyword></KeywordList><CoiStatement>Conflict of Interest Disclosure. The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>17</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34129687</ArticleId><ArticleId IdType="mid">NIHMS1715224</ArticleId><ArticleId IdType="pmc">PMC8667623</ArticleId><ArticleId IdType="doi">10.1111/jnc.15453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander EJ, Niaki AG, Zhang T, Sarkar J, Liu Y, Nirujogi RS, Pandey A, Myong S, Wang J. (2018) Ubiquilin 2 modulates ALS/FTD-linked FUS&#x2013;RNA complex dynamics and stress granule formation. Proc. Natl. Acad. Sci 115, E11485&#x2013;E11494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, Guharoy M., et al. (2017) Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Mol. Cell 65, 1044&#x2013;1055.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard JJ, Otero JH, Scott DC, Szulc E, Martin EW, Sabri N, Granata D., et al. (2018) Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol. Cell 72, 19&#x2013;36.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6179159</ArticleId><ArticleId IdType="pubmed">30244836</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Parker R. (2009) Eukaryotic Stress Granules: The Ins and Outs of Translation. Mol. Cell 36, 932&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813218</ArticleId><ArticleId IdType="pubmed">20064460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel JA, Reitz AB (2013) Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim. Biophys. Acta 1834, 964&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3960997</ArticleId><ArticleId IdType="pubmed">23541532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Monteiro MJ (2015) Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations. PLoS ONE 10, e0130162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Huang B, Shi X, Gao L, Huang C. (2018) Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats. Acta Neuropathol. Commun 6, 122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225656</ArticleId><ArticleId IdType="pubmed">30409191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci 2, 806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure 24, 1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Kolaitis R-M, Kim HJ, O&#x2019;Donovan K, Martyniak B, Colicino E, Hehnly H, Taylor JP, Casta&#xf1;eda CA (2018) Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions. Mol. Cell 69, 965&#x2013;978.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Martyniak B, Canning AJ, Lei Y, Colicino EG, Cosgrove MS, Hehnly H, Casta&#xf1;eda CA (2019) ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner. Structure 27, 937&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, Yang Y., et al. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Siddique T. (2012) UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia. Muscle Nerve 45, 157&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">22246868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, Cleveland DW (2019) Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron 102, 339&#x2013;357.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C, Tiloca C, Del Bo R, Corrado L, Pensato V, Agostini J, Cereda C., et al. (2013) Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 84, 183&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">23138764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin KM, Chang L, Monteiro MJ (2015) ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum. Mol. Genet 24, 2565&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins N, Lin B, Monteiro MJ (2019) Lou Gehrig&#x2019;s Disease (ALS): UBQLN2 Mutations Strike Out of Phase. Structure 27, 879&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267892</ArticleId><ArticleId IdType="pubmed">31167121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, Solovyova A, McWilliams TG, Johnson C, Sahu I., et al. (2016) UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell 166, 935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Stiles SG, Feichtmeier JM, Ramesh N, Zhan L, Scalf MA, Smith LM, Bhan Pandey U, Tibbetts RS (2018) Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS. Hum. Mol. Genet 27, 322&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886165</ArticleId><ArticleId IdType="pubmed">29161404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen MF, Shih AH, Zhou P, Kumar S, Soccio RE, Kedersha NL, Gill G, Howley PM (2000) The hPLIC Proteins May Provide a Link between the Ubiquitination Machinery and the Proteasome. Mol. Cell 6, 409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HS, Uehara T, Tsuruma K, Nomura Y. (2004) Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett. 566, 110&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">15147878</ArticleId></ArticleIdList></Reference><Reference><Citation>Le NTT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, Kvarta MD, et al. (2016) Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS&#x2013;FTD-linked UBQLN2 mutations. Proc. Natl. Acad. Sci 113, E7580&#x2013;E7589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-H, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, Cika J., et al. (2016) C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell 167, 774&#x2013;788.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim PJ, Danner R, Liang J, Doong H, Harman C, Srinivasan D, Rothenberg C., et al. (2009) Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J. Cell Biol 187, 201&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768832</ArticleId><ArticleId IdType="pubmed">19822669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K., et al. (2017) TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron 95, 808&#x2013;816.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah AL, Perry G, Smith MA, Monteiro MJ (2000) Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation. J. Cell Biol 151, 847&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169435</ArticleId><ArticleId IdType="pubmed">11076969</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, et al. (2019) RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron 102, 321&#x2013;338.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzahn MR, Marada S, Lee J, Nourse A, Kenrick S, Zhao H, Ben-Nissan G., et al. (2016) Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles. EMBO J 35, 1254&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910529</ArticleId><ArticleId IdType="pubmed">27220849</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP (2015) Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization. Cell 163, 123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, O&#x2019;Meally R., et al. (2017) Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J 36, 2951&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli FF, Verbeek DS, Bertacchini J, Vinet J, Mediani L, Marmiroli S, Cenacchi G., et al. (2017) Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function. Cell Rep. 20, 2100&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5583511</ArticleId><ArticleId IdType="pubmed">28854361</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M, Ito D, Suzuki N. (2016) Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem. Biophys. Res. Commun 472, 324&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">26944018</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S., et al. (2015) A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell 162, 1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Dutta K, Phaneuf D, Sobue G, Julien J-P (2015) Ubiquilin-2 drives NF-&#x3ba;B activity and cytosolic TDP-43 aggregation in neuronal cells. Mol. Brain 8, 71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S., et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey LM, Safren N, Pithadia AS, Gerson JE, Dulchavsky M, Fischer S, Patel R., et al. (2018) Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci 115, E10495&#x2013;E10504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Chartier L, Amador M-D-M, Lam R, Lautrette G, Nicol M, Machat S., et al. (2017) Novel UBQLN2 mutations linked to Amyotrophic Lateral Sclerosis and atypical Hereditary Spastic Paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiol. Aging 58, 239.e11&#x2013;239.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28716533</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley AM, Prado MA, Poot S. A. H. de, Paulo JA, Ashton M, Dominguez S, Weber M., et al. (2020) Global proteomics of Ubqln2-based murine models of ALS. bioRxiv, 2020.02.22.956524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873701</ArticleId><ArticleId IdType="pubmed">33277362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JJ, Cai A, Greenslade JE, Higgins NR, Fan C, Le NTT, Tatman M., et al. (2020) ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc. Natl. Acad. Sci</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu M, Huang C, Liu X, Huang B, Li N, Zhou H, Xia X-G (2015) Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. (Berl.) 129, 417&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Yan LH, Huang B, Liu M, Liu X, Huang C. (2014) Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation. J. Neurochem 129, 99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24215460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, Mathieu C, Kolaitis R-M, Zhang P, Messing J, Yurtsever U, Yang Z., et al. (2020) G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules. Cell 181, 325&#x2013;345.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng T, Yang Y, Casta&#xf1;eda CA (2020) Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery. Biochem. J 477, 3471&#x2013;3497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737201</ArticleId><ArticleId IdType="pubmed">32965492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>